James M. Fries Rx-360
Jim Fries is a success-based executive with more than 25 years of experience building medical device and diagnostic companies across all pathways, including growth-oriented commercial initiatives, regulatory, and market access. Jim has been involved in driving thought-leader panels and committees within the areas of vascular intervention, cardiometabolics, diabetes, orthopedics, and pharmaceutical quality, which has resulted in numerous guidelines and consensus papers. Jim became CEO of Rx-360 in February of 2018, as a way of fulfilling his personal lifelong commitment to patient safety. Jim's expertise includes:
- Pharmaceutical Supply Chain Security
- Remote Pharmaceutical Auditing
- Managing Pharmaceutical Supply Chain Integrity and Material Quality During a Pandemic (COVID-19)
- Data Integrity
- Joint Audit Program® for the Pharmaceutical Industry
- Utilizing Industry Consortia in Pharma